Novavax, Inc. (NVAX) Stock Price History
Historical prices from 2011 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
NVAX Stock Price Trajectory (2011–2026)
As of March 1, 2026, Novavax, Inc. (NVAX) trades at $10.14, representing a +21.7% return over the past year. The stock has delivered a -46.9% return over five years, reflecting challenging market conditions.
The stock reached its all-time high of $331.68 on February 9, 2021. From this peak, NVAX has corrected -96.9%, currently trading 31% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers BNTX (-2.4% 1Y), MRNA (+73.0% 1Y), and SMMT (-19.8% 1Y), NVAX has underperformed the peer group average. Compare NVAX vs BNTX →
Historical Price Data
Showing 30 of 3,650 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 11.15 | 11.15 | 9.81 | 10.14 | 10 | -9.38% |
| 2026-02-26 | 9.75 | 11.97 | 9.70 | 11.19 | 11 | +17.42% |
| 2026-02-25 | 9.52 | 9.74 | 9.29 | 9.53 | 9 | +0.74% |
| 2026-02-24 | 9.35 | 9.77 | 9.31 | 9.46 | 9 | +1.07% |
| 2026-02-23 | 9.13 | 9.60 | 9.10 | 9.36 | 9 | +1.74% |
| 2026-02-20 | 9.10 | 9.53 | 9.04 | 9.20 | 9 | -0.27% |
| 2026-02-19 | 8.67 | 9.30 | 8.53 | 9.22 | 3.93M | +6.16% |
| 2026-02-18 | 8.65 | 8.85 | 8.56 | 8.69 | 1.73M | -0.46% |
| 2026-02-17 | 8.52 | 8.80 | 8.52 | 8.73 | 154K | +0.34% |
| 2026-02-13 | 8.55 | 8.91 | 8.48 | 8.70 | 3.22M | +3.33% |
| 2026-02-12 | 8.97 | 9.19 | 8.25 | 8.42 | 4.11M | -6.13% |
| 2026-02-11 | 8.91 | 9.28 | 8.54 | 8.97 | 5.04M | +2.51% |
| 2026-02-10 | 8.69 | 9.02 | 8.60 | 8.75 | 3.67M | +0.57% |
| 2026-02-09 | 8.19 | 8.73 | 8.02 | 8.70 | 3.99M | +5.45% |
| 2026-02-06 | 8.01 | 8.31 | 7.85 | 8.25 | 3.25M | +4.83% |
| 2026-02-05 | 8.17 | 8.32 | 7.84 | 7.87 | 4.15M | -4.84% |
| 2026-02-04 | 8.42 | 8.62 | 8.16 | 8.27 | 3.50M | -1.19% |
| 2026-02-03 | 8.64 | 8.85 | 8.09 | 8.37 | 3.77M | -3.68% |
| 2026-02-02 | 8.67 | 8.87 | 8.44 | 8.69 | 3.33M | -1.81% |
| 2026-01-30 | 9.22 | 9.29 | 8.65 | 8.85 | 5.01M | -6.25% |
| 2026-01-29 | 9.25 | 9.60 | 9.23 | 9.44 | 4.49M | +2.28% |
| 2026-01-28 | 9.74 | 9.94 | 9.16 | 9.23 | 5.31M | -6.01% |
| 2026-01-27 | 9.75 | 10.20 | 9.62 | 9.82 | 6.79M | +1.97% |
| 2026-01-26 | 9.32 | 10.02 | 9.25 | 9.63 | 6.84M | +5.02% |
| 2026-01-24 | 9.70 | 9.70 | 9.15 | 9.17 | 7.54M | 0.00% |
| 2026-01-23 | 9.70 | 9.70 | 9.15 | 9.17 | 7.59M | -5.95% |
| 2026-01-22 | 9.86 | 10.13 | 9.50 | 9.75 | 9.37M | -1.52% |
| 2026-01-21 | 8.28 | 9.98 | 8.20 | 9.90 | 16.46M | +20.73% |
| 2026-01-20 | 8.22 | 8.75 | 7.98 | 8.20 | 11.85M | +2.37% |
| 2026-01-16 | 7.77 | 8.33 | 7.73 | 8.01 | 5.44M | +2.96% |
See NVAX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NVAX Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare NVAX vs AGIO
See how NVAX stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has NVAX stock performed recently?
NVAX returned +21.7% over the past year, beating its 5-year annualized CAGR of -46.9%. The stock trades above its 200-day moving average, confirming the uptrend.
What is NVAX's all-time high price?
Novavax, Inc. reached $331.68 on 2021-02-09. The 52-week high is $11.97. Current 1-year return of +21.7% places the stock closer to historical peaks.
Where can I download NVAX historical price data?
This page provides NVAX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2011-2026, downloadable in CSV format.